Robert J. Snyder, D.P.M., MSc, C.W.S.
Professor and Director of Clinical Research

Education

  • 1967-1971 Long Island University,  Brooklyn Campus, Brooklyn, New York;  Bachelors of Science ( B.S. Biology )
  • 1971-1975 New York College of Podiatric Medicine, New York, New York; Doctor of Podiatric Medicine (D.P.M.)
  • 1988 Florida International University, Miami, Florida;  Coursework in Clinical Nutrition
  • 2012- Master of Science in Wound Healing and Tissue Science, Cardiff University, University of Wales School of Medicine, UK

Post-Graduate Residency Training

  • 1975-1976 Jewish Memorial Hospital, New York, New York;  Residency in Podiatric Medicine and Surgery
  • 1976-1977 Metro-Plaza Surgical Center, Kansas City, Missouri; 2nd year resident in Podiatric Surgery.
  • 1977-Present  Thousands of hours of post-graduate courses relating to wound management and limb salvage, Podiatric Medicine and surgery, as well as numerous general medical topics

Board Certification, Honors and Awards

  • Diplomat, American Board of Podiatric Surgery, Board Certified in Foot and Ankle Surgery 1983; recertified in 1993 and 2003
  • Diplomat, American Academy of Wound Management, Certified Wound Specialist (C.W.S.); 1999-Present
  • Fellow, American College of Foot and Ankle Surgeons; 1999-Present
  • Member, Association of the Advancement of Wound Care, 1999-Present
  • Fellow, American Professional Wound Care Association, 2004-Present
  • Fellow, American College of Wound Care, 2005
  • Fellow, College of Certified Wound Specialists 2005-Present
  • Certified,  Hyperbaric Oxygen Therapy 1997
  • Recipient, DuoDerm Research Scholarship, ConvaTec Corporation, Presented at Queen Ann College, Oxford University, Oxford, England;  1999
  • Selected to Participate in the renowned Wound Healing Summer School, Oxford University, Oxford, England, 1999
  • Diabetic Limb Salvage Symposium Hobson Award, 2009

Academic Appointments

  • Professor and Director of Clinical Research at Barry University School of Podiatric Medicine 2011
  • National Podiatric Medical Director, Diversified Clinical Services  2010-Present
  • Professor (Adjunct) Temple University College of Podiatric Medicine 2009- Present
  • Medical Director- Independent Consultant, Systagenix Wound Management 2009- Present
  • Medical Director, Wound Healing & Hyperbaric Center at University Hospital, Tamarac, Florida; 2002- 2012
  • Clinical Faculty, PSR 36/PGY 3 Podiatric Residency Program, Northwest Medical Center, Margate, Florida 1999-2008
  • Director, Wound Management Education, Northwest Medical Center, 2000-2008
  • Medical Director, Wound Healing Center, Northwest Medical Center, Margate, Florida 2004- 2008

Committees and Editorial Positions

  • President 2010, American Board of Wound Management
  • President  2012,  Association for the Advancement of Wound Care
  • Member, Board of Directors, American Academy of Wound Management;  2004-2009
  • Member, Board of Directors, Association for the Advancement of Wound Care; 2005-2011
  • Member, Medical Advisory  Board, American Professional Wound Care Association, 2005
  • Member, Medical Advisory Board, Ivivi Technologies, 2004-Present
  • Chair, CME Committee, University Hospital, January 2004-Present
  • Member Credentials and Qualifications Committee, University  Medical Center;  January 2004-Present
  • Chair, Skin & Wound Committee, University Hospital;  January 2004-Present
  • Fellow, American Professional Wound Care Association, September 2004
  • Editorial Advisory Board and Section Chair, WOUNDS, HMP Communications; 2010-Present
  • Editorial Advisory Board, Ostomy Wound Management, HMP Communications; 2002-Present
  • Consulting Editor, Podiatry Management Magazine;  2002-Present
  • Member, Credentials and Qualifications Committee, Northwest Medical Center;  1999-2008
  • Member, Executive Committee, Coral Springs Surgical Center,  2000
  • Editor, Wound Care Q&A Column, Podiatry Today Magazine;  1999-2003
  • Contributing Editor, Podiatry Today Magazine 1999-2003
  • Ad Hoc Reviewer, Ostomy Wound Management, HMP Communications;  2000-2002
  • Ad Hoc Reviewer, New England Journal of Medicine, 2005
  • Advisory Board, Podiatry Online, 2001
  • Editor, recurrent column on wound care and related issues, Podiatry Management; 2003-Present
  • Assistant Editor , The Journal of The American College of Certified Wound Specialists; 2009-2010
  • Membership Committee, Wound Healing Society; 2004- 2009
  • Advisory Board, PRESENT Courseware for Podiatric Resident Education 2004

Consultant and /or Principal Investigator (P/I) Positions

  • Johnson & Johnson Wound Management Worldwide, a division of Ethicon, Inc.;  Speakers Bureau 1997- 2009
  • Systagenix Wound Management; Speakers Bureau
  • Smith & Nephew, Inc.; Speakers Bureau
  • Pfizer Pharmaceuticals; Speakers Bureau
  • Organogenesis; Speakers Bureau
  • KCI; Speakers Bureau/ Consultant
  • Advanced Bio Healing; Scientific Advisor
  • Human Genome Sciences, P.I., Clinical Protocol KGF-2 WHO4 2001
  • Novartis Pharmaceuticals:  Clinical Protocol KGF-2 WHO4 2001
  • Principal Investigator, Johnson & Johnson Wound Management Worldwide, a division of Ethicon, Inc.: Clinical Protocol 400-04-001
  • Principal Investigator, King Pharmaceuticals Research and Development Inc.:  Protocol Number MRE0094P-201
  • Principal Investigator, KeraCure, Inc.  Protocol Number KC-002 
  • Principal Investigator, Genentech, Inc.  Protocol Number VGF3554g
  • Principal Investigator, Advanced BioHealing, Inc. Protocol Number P001-001-B
  • Principal Investigator, Intercytex, Ltd. Protocol Number 02-VLU-003
  • Principal Investigator, Abbott Laboratories, Protocol Number BK15
  • Principal Investigator, Healthpoint, Ltd.  Protocol Number 802-247-09-015
  • Principal Investigator, Integra Life Sciences, Corp. Protocol Number IDRT/DFU US-2009-3
  • Principal Investigator, CoDa Therapeutics, Inc.  Protocol Number NEX-ULC-007

Research Projects

  1. CoDa Therapeutics, Inc., Protocol Number NEX-ULC-007 “A Randomized, Parallel Group, Dose-Ranging, Controlled, Multi-center Study to Assess the Efficacy and Safety of Nexagon® in the Treatment of Subjects with a Venous Leg Ulcer”  June 2011 – Present
  2. Integra LifeSciences, Protocol Number IDRT/DFU US-2009-3 “A Multi-Center Randomized, Controlled Clinical Trial to Evaluate the Safety and Effectiveness of Integra Dermal Regeneration Template for the Treatment of Neuropathic Diabetic Foot Ulcers”  June 2010 - Present
  3. Healthpoint, Ltd.,  Protocol Number 802-247-09-015 “A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers”  June 2009 – June 2011
  4. Advanced BioHealing,  Protocol Number ABH-Dermagraft-001-08 “A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft in Subjects with Venous Leg Ulcers DEVO-Trial”  June 2009 - Present
  5. Abbott Laboratories, Protocol Number BK15 “Evaluation Of A Medical Food For Chronic Wounds”  October 2008 – September 2010
  6. Intercytex, Ltd. – Protocol Number 02-VLU-003 “A Prospective, Multi-Centre, Double Blind Randomized Placebo Controlled Clinical Trial To Evaluate The Safety And Efficacy Of ICXP007
  7. In A Phase III Trial With Four layer Therapeutic Compression, For the Treatment of Non-Infected Skin Leg Ulcers, Due To Venous Insufficiency” October 2007
  8. Advanced BioHealing Inc. - Protocol Number P001-001-B “An Initial Evaluation of the Safety
    And Activity of Celaderm™ Treatment Regimens In Healing Venous Leg Ulcers” January 2007
  9. Genentech, Inc. – Protocol Number VGF3554g “A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factory (Telbermin) for Induction of Healing of Diabetic Foot Ulcers”.
    June 2006
  10.  King Pharmaceuticals Research and Development Inc.-  Protocol Number MRE0094P-201
  11. “A Multi-Center, Double-Blind, Randomized, Parallel, Vehicle- and Standard Care-Controlled, Dose-Ranging Study Assessing the Safety and Efficacy of MRE0094 Gel When Applied Topically for 90 Days to Subjects with Diabetic, Neuropathic, Foot Ulcers”.  January 2006
  12. KeraCure, Inc.- Protocol Number KC-002  “A Prospective, Randomized, Controlled, Unmasked,
    Multiple Treatment, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of an      Interactive Wound Dressing Containing Cultured Keratinocytes versus Conventional Wound Therapy for the Treatment of Diabetic Foot Ulcers”.  December 2005- March 2007
  13. Johnson & Johnson Wound Management Worldwide-A division of Ethicon-Protocol Number 400-04-001 “A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC                                                                                                          Antimicrobial Matrix in Full-thickness Neuropathic Diabetic Foot ulcers”.  May 2004
  14. Johnson & Johnson Wound Management Worldwide-A division of Ethicon-Protocol           Number  400-04-002 “A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers”.  August 2004
  15. Nova Cal Pharmaceuticals. Protocol Number CLO401: “A Study to Evaluate the Clinical Effectiveness of a New Topical Antimicrobial”.  May 2005
  16. Human Genome Sciences Clinical Protocol KGF-2 WH4: “A randomized, double blinded parallel-group placebo-controlled, multi-center study to evaluate the efficacy and safety of Repifermin (KGF-2) in subjects with venous ulcers”. 10 July 2001
  17. Novartis Pharmaceuticals: Protocol Number 99-062: CGSO769-US07:  “An open-label study to evaluate the safety and efficacy of Apligraf in the treatment of venous leg ulcers” Oct. 13, 1999.

Work History

  • 1992-Present   Private Practice, Tamarac, Florida
  • 1977-1992  Co-director, Foot Health Center, Boynton Beach, Florida
  • 1995-2000  Faculty Physician, Wound Healing Institute at Florida Medical Center, Lauderdale Lakes, Florida
  • 2000-Present   Faculty Physician, Wound Healing Center at University Hospital, Tamarac, Florida.
  • 2002-Present  Medical Director, Wound Healing & Hyperbaric Center at University Hospital, Tamarac, Florida
  • 2004- 2008  Medical Director, Wound Healing Center at Northwest Medical Center, Margate, Florida
  • 1996-Present   Faculty Physician, Wound Healing Center at Northwest Medical Center, Margate, Florida

Current Hospital Affiliations

  • 1977-Present    University Hospital, Tamarac, Florida
  • 1996-Present    Northwest Medical Center, Margate, Florida
  • 2001-Present    Coral Springs Medical Center, Coral Springs, Florida
  • 2011-Present    Hialeah Hospital, Hialeah, Florida
  • 2011-Present    Mt Sinai Hospital, Miami, Florida

Active Licenses

1975-Present  State of Florida  #PO 0000908

Community Service

President and Chairman of the Executive Committee, Temple Beth Orr, Coral Springs,  Florida 1997-1999

Publications

  1. Snyder RJ, Cullen B.  Point of Care Diagnostic Tests in Wound Management:  Targeted Therapy for Excessive Protease Activity- The First Frontier.  Wound Care & Hyperbaric Medicine.  July- Sept 2011; 2(3): 59-69
  2. Snyder R et al.  International Consensus.  The role of proteases in wound diagnostics.  An expert working group review.  London:  Wounds International, 2011
  3. Snyder RJ, Kirsner RS, Warriner RA, Lavery LA, Hanft JR, Sheehan, P.  Consensus Recommendations on Advancing the Standard of Care for Treating Neuropathic Foot Ulcers in Patients with Diabetes.  Ostomy Wound Management, HMP Communications. Supplement to April 2010
  4. Snyder RJ, Cardinal M, Dauphinee DM, Stavosky J.  A Post-hoc Analysis of Reduction in Diabetic Foot Ulcer Size at 4 Weeks as a Predictor of Healing by 12 Weeks.  Ostomy Wound Management, HMP Communications.  March 2010; 56(3):  44-50
  5. Snyder RJ, Hanft J.  Diabetic Foot Ulcers- Effects on Quality of Life, Costs, and Mortality and the Role of Standard Wound Care and Advanced-Care Therapies in Healing:  A Review.  Ostomy Wound Management, HMP Communications.  November 2009; 55(11):  30-36
  6. Snyder RJ.  Skin Cancer and Wounds in the Geriatric Poplulation:  A Review.Ostomy Wound Management, HMP Communications.  April 2009;55(4):64-76
  7. Snyder R.  Is there a place for topical growth factor therapy in acute wound healing?  Podiatry Management, 2006
  8. Snyder R.  Compliance in wound management. Podiatry Management. 2006
  9. Snyder R, Hans D.  Maggot therapy in the treatment of chronic wounds  Podiatry Management., 2006
  10. Snyder R.  Skin cancers and wounds in the geriatric population. In: Geriatric Dermatology (R. Norman, ed). 2006
  11. Snyder RJ.  Proteases and wound healing.  Physicians News letter, University Hospital, 2005
  12. Snyder RJ.  An interview with Peter King:  Offloading the diabetic foot. Podiatry Management. 2005
  13. Snyder RJ, Julien W.  Endovascular surgery as part of the wound healing algorithm.  Parts 1 and Podiatry Management, 2005
  14. Snyder RJ.  Physiology of  Wound Healing. Chapter in Wound Healing and Suction Wound Therapy, Published in China and translated into mandarin, 2005
  15. Snyder RJ, et al.  Round Table Discussion: Wound Care. Podiatry Management, June 2005
  16. Snyder RJ, Glick B.  Discussions about the role of the dermatologist as part of the wound healing team.  Podiatry Management, June 2005
  17. Snyder RJ, Hagberg  S.  The role of physiotherapy and electro-magnetic fields in wound healing.  Podiatry Management, June 2005
  18. Snyder RJ.  Ten misconceptions about wound bed preparation. Podiatry Management.  June 2005
  19. Snyder RJ, Hanft J, Serena T. The changing microenvironment of chronic wounds.  June 2005 as a supplement to Wounds and Ostomy Wound Management
  20. Snyder RJ.  Bacteria and wound healing. Physicians News letter, University Hospital, 2005
  21. Snyder RJ.  Treatment of nonhealing ulcers with allograft. Chapter in Clinics in Dermatology Elsevier Inc, scheduled for publication July 2005
  22. Snyder RJ.  Proteases in Wound Healing.  Podiatry Management, September 2004
  23. Snyder RJ.  My Scope of Practice-Championing the podiatrist role in wound care. Ostomy Wound Management, HMP Communications.  June 2004
  24. Snyder RJ.  Ten Misconceptions regarding wound management.  Podiatry Management, June/July 2004
  25. Snyder RJ.  Identifying wound etiology:  The key to healing.  Podiatry Management, April/May 2004
  26. Snyder RJ   Dermagraft as an adjunct in the treatment of venous leg ulcers.  Poster Presentation -Wound Healing Society Conference Atlanta, Ga.  May 23-26, 2004
  27. Snyder RJ.  VAC therapy in a wound care center. Physicians News letter, University Hospital, 2004
  28. Snyder RJ.  Vacuum assisted closure therapy –VAC 101.  Podiatry Management, February 2004
  29. Snyder RJ.  Vacuum assisted closure therapy –Part 2.   Podiatry Management, March 2004
  30. Snyder RJ.  Off-loading diabetic foot wounds for optimal healing.  Podiatry Management, November/December, 2003
  31. Snyder RJ, Stillman R, Julien W.  Taking a closer look at venous ulcers.  Podiatry Management, June/July 2003
  32. Snyder RJ, Stillman R, Weiss SD.  Epidermoid cancers that masquerade as venous ulcer disease. Ostomy Wound Management, April 2003
  33. Snyder RJ. The importance of biopsy in wound management.  Podiatry Management, March 2003
  34. Snyder RJ.  Taking another look at total contact casting.  Podiatry Management, February 2003
  35. Snyder RJ.  Ten more key wound management misconceptions.  Podiatry Management, November/December 2003
  36. Snyder RJ.  Mastering difficult heel ulcers.   Podiatry Today, November 2003
  37. Snyder RJ.  An illuminating interview with David Armstrong, DPM.  Podiatry Management,  November/December 2002
  38. Snyder RJ.  MRSA Infections in podiatric practice-Wound care & Diabetes Q&A.  Podiatry Management, October 2002
  39. Snyder RJ.  Key insights on using Apligraf successfully-Wound Care Q&A.  Podiatry Today, March 2002
  40. Snyder RJ.  Pyoderma Gangrenosum-Wound Care & Diabetes Q&A.  Podiatry Management, August 2002
  41. Snyder RJ.  Endovascular surgery  An interview with Dr. William “Bill” Julien  Podiatry Management, June/July 2002
  42. Snyder RJ.  Ten key wound management misconceptions.  Podiatry Management, June/July 2002
  43. Snyder RJ, Ribotsky B, Zachow K.  Vacuum Assisted Closure (VAC).  Podiatry Management, April/May 2002
  44. Snyder RJ.  How to treat severe post-op pain.  Wound care Q&A Podiatry Today,  May 2002
  45. Snyder RJ, Lanier K.  Offloading difficult wounds and conditions in the diabetic patient. Ostomy Wound Management, January 2002
  46. Snyder RJ.  Graftskin (Apligraf) and Regranex Gel:  An Overview  Podiatry Management, November/December 2001
  47. Snyder RJ, Delbridge T, Doyle H.  A pictorial review of a technique for split-thickness skin graft Coverage of foot and lower leg wounds:  discussion and nursing implications.  Ostomy Wound Management, HMP Communications, December 2001
  48. Snyder RJ.  Vacuum assisted closure (VAC) in podiatric practice:  case study and discussion. Footprints Magazine, the Official Publication of the Florida Podiatric Medical Association Publication, December 2001
  49. Snyder RJ, Goldberg A.  Pain Management of chronic wounds.  Wound Care Q&A (Snyder editor), Podiatry Today, November 2001
  50. Snyder RJ, Ross S.  Discussion of infection in the chronic wound patient.  Wound Care Q&A (Snyder RJ, editor).  Podiatry Today, September 2001
  51. Snyder RJ, Brill, Ross S.  How to detect infection in chronic wounds.  Wound Care Q&A (Snyder RJ, editor).  Podiatry Today, July 2001:  78-79
  52. Snyder RJ, Abramson L, Brill L, Saye DE.  Essential keys to success in treating unusual wounds. Podiatry Today July 2001:  50-54
  53. Snyder RJ, Davis J.  Physical therapy as an adjunct to wound healing.  Podiatry Today July 2001:  40-48
  54. Snyder RJ.  Graftskin (Apligraf) used to heal defects after Mohs surgery.  Poster Presentation, Wound Healing Society Meeting, New Mexico June 16-18, 2001
  55. Snyder RJ, Stillman R, Lieberman J., Glick B.  Improve your understanding of how to approach often misdiagnosed wounds. Part I  Wound Q&A (Snyder RJ, ed).  Podiatry Today, March 2001
  56. Snyder RJ, Stillman R, Glick B.  Improve your understanding of how to approach often misdiagnosed wounds.  Part II.   Wound Q&A (Snyder RJ, ed).  Podiatry Today, April 2001
  57. Snyder RJ.  Everything you always wanted to know about skin grafting.  Podiatry Today, April 2001
  58. Snyder RJ, Weiss SD.  Subcutaneous T-cell lymphoma originally diagnosed as venous stasis ulcer:  case report and discussion.  Wounds:  A Compendium of Clinical Research and Practice: April/May 2001;13(2):46-52
  59. Snyder RJ, Cohen MM, Livingston J, et al.  Osteomyelitis in the diabetic patient:  medical, surgical and alternative treatments.  Part II   Ostomy Wound Management, March 2001; 47(3):24-41
  60. Snyder RJ, Cohen MM, Livingston J, et al.  Osteomyelitis in the diabetic patient:  diagnosis and microbiology.  Part I  Ostomy Wound Management, January 2001 47(1):18-30
  61. Snyder RJ.  Hyperbaric oxygen:  a call for evidence based medicine.  Podiatry Today, January 2001:40-47
  62. Snyder RJ, Rehm K, Harriot B.  Improve your understanding of how to manage pressure ulcers. Wound Care Q&A (Snyder RJ, ed) Podiatry Today, January 2001:73-75
  63. Snyder RJ. Commonly asked questions concerning Apligraf.  Wound Care Q&A (Snyder RJ, editor) Podiatry Today, January 2001
  64. Snyder RJ (ed).  Improve your understanding of how to manage venous ulcers.  Podiatry Today, November/December 2000
  65. Snyder RJ, Beylin M, Weiss S.  Calciphylaxis and its relation to end-stage renal disease:  a literature review and case reports.  Ostomy Wound Management, October 2000;46(10):40-47
  66. Snyder RJ.  Round Table discussion:  wound care.  Podiatry Management, October 2000
  67. Snyder RJ.  Charcots Foot:  An in-depth look at medical treatments and surgical options Part II Wound Care Q&A.  Podiatry Today, September 2000
  68. Snyder RJ.  Improve  your understanding of how to manage Charcots foot:  Part I, etiology and diagnosis Wound Care Q&A,  Podiatry Today, July/August 2000
  69. Snyder RJ. Cadaveric allograft and becaplermin gel:  potentially synergetic effect for accelerated healing of recalcitrant wounds.  Poster Presentation, The Wound Healing Society Meeting, Toronto, Canada, June 2000
  70. Snyder RJ.  Wound Management:  a global perspective.  Wounds:  A compendium of clinical Research and Practice. January/ February 2000;12(1):A12-A19
  71. Snyder RJ.  Wound management:  a global perspective based on experiences as exchanges ambassador England 1999.  Wound/Ostomy Management. September 1999;45(9):26-30
  72. Snyder RJ.  Treatment of diabetic foot ulcers: a multidisciplinary approach.  Podiatry Management June 1999; 61-70.
  73. Snyder RJ, Simonson D.  Cadaveric allograft as an adjunct to wound healing.  Journal of Foot and Ankle Surgery. March/April 1999;38(2)
  74. Snyder RJ.  Back cover/liner notes.  From:  O’Brien CJ.  A Joyful Diabetic for Thirty-Five Years, Todd &Honeywell, Inc.  Great Neck, New York  1983
  75. Snyder RJ.  Contact dermatitis as a surgical complication.  Journal of Foot Surgery. 1983

Internet Publications

  • Snyder RJ.  Venous ulcer disease.  Podiatry Online, January 2000
  • Snyder RJ.  Pressure ulcers.  Podiatry Online, February 2000
  • Snyder RJ.  Wound management in the 21st century.  An editorial. Podiatry Online, January 2001
  • Snyder RJ.  Apligraf and Mohs surgery.  Podiatry Online, 2001
  • Snyder RJ.  Vacuum assisted closure.  Podiatry Online, October 2001
  • Snyder RJ.  Osteomyelitis-The Diabetic Foot.  PRESENT Courseware for Podiatric Resident Education, Lecture Series, January 2004
  • Snyder RJ.  Resistant Infections.  PRESENT Courseware for Podiatric Resident Education, Lecture Series, January 2004
  • Snyder RJ.  Advanced wound management.  PRESENT Courseware for Podiatric Resident Education, Lecture Series, January 2004
mask

Oh oh ....

We are sorry but it appears that JavaScript is disabled on your browser.
Our site is very interactive and it requires JavaScript to be enabled.
Click on the link below for instructions on how to enable JavaScript on your browser.

Enable JavaScript on your browser
+ +